Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Control of Myopia Using Novel Spectacle Lens Designs

NCT: NCT03623074 · ACTIVE_NOT_RECRUITING

NCT IDNCT03623074
StatusACTIVE_NOT_RECRUITING
Start Date2018-07-16
Completion2026-12-31

Brief Summary

Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.

Frequently Asked Questions

What is Control of Myopia Using Novel Spectacle Lens Designs?

Control of Myopia Using Novel Spectacle Lens Designs is a clinical trial registered under NCT03623074. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03623074?

The current status of NCT03623074 (Control of Myopia Using Novel Spectacle Lens Designs) is: ACTIVE_NOT_RECRUITING.

When did Control of Myopia Using Novel Spectacle Lens Designs start?

Control of Myopia Using Novel Spectacle Lens Designs started on 2018-07-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑